Bapineuzumab

Ofatumumab

1,10-Phenanthroline, 2,9-dimethyl-4,7-diphenylsulfonyl-, disulfo deriv., disodium salt (1:2) (ACI)

DNA, sodium complexes (15C)

Oligomycin A (6CI, 7CI, 8CI)

Eudesmol (6CI, 7CI)

Tectoruside (9CI)

Lumiliximab

Immunoglobulin G4 [228-proline], anti-(human ectonucleoside triphosphate diphosphohydrolase 1) (human monoclonal TTX-030 γ4-chain), disulfide with human monoclonal TTX-030 κ-chain, dimer (ACI)

Briakinumab (9CI, ACI)

Immunoglobulin G4 [229-proline,436-arginine,437-phenylalanine,446-proline], anti-(human natriuretic peptide receptor A) (human monoclonal REGN9035 γ4-chain), (227→8′),(230→11′)-bis(disulfide) with immunoglobulin G4 [10′-proline,217′-histidine,218′-tyrosine] (human γ4-chain C region C-terminal fragment), disulfide with human monoclonal REGN9035 κ-chain (ACI)

3-(Dimethylamino)naphth[2,3-d]isothiazole-4,9-dione (ACI)

Immunoglobulin G4 [229-proline], anti-(human ectonucleoside triphosphate diphosphohydrolase 1) (human monoclonal SRF617 γ4-chain), disulfide with human monoclonal SRF617 κ-chain, dimer (ACI)

Immunoglobulin G1 [de-236-glycine,de-C-terminal lysine], anti-(human CD40 antigen) (human monoclonal LVGN7409 γ1-chain), disulfide with human monoclonal LVGN7409 κ-chain, dimer (ACI)

Immunoglobulin G1, anti-(human leukemia inhibitory factor) (human-Wistar rat monoclonal AZD0171 γ1-chain), disulfide with human-Wistar monoclonal AZD0171 κ-chain, dimer (ACI)

Immunoglobulin G1 [de-C-terminal-lysine], anti-(human receptor TIGIT) (human monoclonal M6223 γ1-chain), disulfide with human monoclonal M6223 κ-chain, dimer (ACI)

Immunoglobulin G2 [311-alanine], anti-(human interleukin 6) (human monoclonal RG6179 γ2-chain), disulfide with human monoclonal RG6179 κ-chain, dimer (ACI)

Apolizumab

1-(3′-Chloro-2,5′-difluoro-5-methoxy[1,1′-biphenyl]-4-yl)-1,2-dihydro-N-3-isoxazolyl-2-oxo-6-quinolinesulfonamide (ACI)

1,4-Dihydro-1-methyl-N-(5-nitro-1,2-benzisothiazol-3-yl)-4-oxo-3-pyridinecarboxamide (ACI)